SCHEMBL16844784

SCHEMBL16844784

CCCOC1CCC(C2CCC(OCCC)C(F)C2F)C(F)C1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16844783 0.94 ALDH1A1 (0.31) —
SCHEMBL16844762 0.93 — —
SCHEMBL16844765 0.93 PPP5C (0.32) —
SCHEMBL15062130 0.91 — —
SCHEMBL16844697 0.91 GBA1 (0.37) —
SCHEMBL16844698 0.89 GBA1 (0.40) —
SCHEMBL20998319 0.88 GBA1 (0.33) —
SCHEMBL16844764 0.87 — —
SCHEMBL20998296 0.85 — —
SCHEMBL20998210 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2886627-B1 Liquid crystalline medium MERCK PATENT GMBH (DE) 2019-05-15 — — EP disclosed
EP-2886627-A1 Liquid crystalline medium Merck Patent GmbH (DE) 2015-06-24 — — EP disclosed
Send feedback